Topical steroid composition and method
DCFirst Claim
1. A storage stable, topical lotion composition for treating a skin disorder or condition, said composition comprising:
- a halobetasol material comprising halobetasol or its pharmaceutically acceptable salts, esters, and solvates; and
a pharmaceutically acceptable carrier which includes;
(a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate, wherein the amount of said halobetasol material after storage for six months at 40°
C. is >
98.5% of the total amount of halobetasol material present at the time of manufacture of the topical lotion, wherein the amount of degradation of said halobetasol material after storage for 26 months at 30°
C. is <
1% of the total amount of halobetasol material present at the time of manufacture of the topical lotion and wherein the amount of degradation of said halobetasol material after storage at 25°
C. for 30 months is <
3% of the total amount of halobetasol material present at the time of manufacture of the topical lotion, andwherein the ratio of said fatty alcohols and alkoxylated fatty alcohols to said humectants, to said diisopropyl adipate is, on a weight basis, in the range of 30-60;
30-60;
5-15.
2 Assignments
Litigations
0 Petitions
Accused Products
Abstract
Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include a halobetasol material comprising halobetasol or its pharmaceutically acceptable salts, esters, and solvates; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate. Storage stable, topical lotion compositions for treating corticosteroid-responsive dermatoses are provided by the present invention which include 0.05% halobetasol propionate; and a pharmaceutically acceptable carrier which includes: (a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate.
41 Citations
29 Claims
-
1. A storage stable, topical lotion composition for treating a skin disorder or condition, said composition comprising:
- a halobetasol material comprising halobetasol or its pharmaceutically acceptable salts, esters, and solvates; and
a pharmaceutically acceptable carrier which includes;
(a) one or more fatty alcohols and/or one or more alkoxylated fatty alcohols, (b) one or more polyol humectants, and (c) diisopropyl adipate, wherein the amount of said halobetasol material after storage for six months at 40°
C. is >
98.5% of the total amount of halobetasol material present at the time of manufacture of the topical lotion, wherein the amount of degradation of said halobetasol material after storage for 26 months at 30°
C. is <
1% of the total amount of halobetasol material present at the time of manufacture of the topical lotion and wherein the amount of degradation of said halobetasol material after storage at 25°
C. for 30 months is <
3% of the total amount of halobetasol material present at the time of manufacture of the topical lotion, andwherein the ratio of said fatty alcohols and alkoxylated fatty alcohols to said humectants, to said diisopropyl adipate is, on a weight basis, in the range of 30-60;
30-60;
5-15. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)
- a halobetasol material comprising halobetasol or its pharmaceutically acceptable salts, esters, and solvates; and
Specification